CROI 2012: U.S. Black Women Have Higher Rates of HIV Infection and AIDS Death
- Details
- Category: HIV Disease Progression
- Published on Wednesday, 21 March 2012 00:00
- Written by Liz Highleyman
Urban black women in the U.S. are 5 times more likely to become infected with HIV than previously estimated, and are twice as likely to die of AIDS-related causes, according to 2 posters presented this month at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.
CROI 2012: The Real Life Challenge of HIV Treatment as Prevention [VIDEO]
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 March 2012 00:00
- Written by Gregory Fowler
"Treatment as prevention" was a widely referenced topic at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle, and has been a dominant theme in HIV/AIDS news for the past couple years. Rick Elion explains why this approach may be difficult to put into practice.
CROI 2012: Vorinostat -- A First Step on the Road Towards a Cure for HIV
- Details
- Category: Search for a Cure
- Published on Friday, 16 March 2012 00:00
- Written by Matt Sharp
Researchers from the University of North Carolina at Chapel Hill have for the first time shown that HIV can be purged from resting latent T-cells, an important early step in moving research forward on one of the potential HIV cure strategies, according to a report at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle.
CROI 2012: Long-term Tenofovir Promotes HBsAg Decline in HIV/HBV Coinfected People
- Details
- Category: HIV/HBV Coinfection
- Published on Tuesday, 20 March 2012 00:00
- Written by Liz Highleyman
Hepatitis B surface antigen (HBsAg) levels declined steadily in HIV/HBV coinfected patients treated with tenofovir for up to 8 years, especially those with rising CD4 T-cell counts, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle.
Coverage of the 2012 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Friday, 16 March 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com's complete coverage of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), March 5-8, 2012.
Featuring new HIV drugs, HIV cure research, biomedical prevention, HIV-related conditions and complications, basic science, hepatitis C, and HIV/HCV coinfection.
HIVandHepatitis.com CROI 2012 section
3/16/12
More Articles...
- CROI 2012: HIV Brain Impairment: Who Gets It, and Why?
- CROI 2012: Uncontrolled HIV Linked to Faster Lung Function Decline
- CROI 2012: Studies Look at Interactions Between New Hepatitis C Drugs and HIV Antiretrovirals
- CROI 2012: Electrocautery Superior to Imiquimod or 5-Fluorouracil for Treatment of Anal Neoplasia
Web Design and Development by